Event Details
China's new government procurement framework, effective from January 2026, introduces clear criteria for determining when products can be considered "domestic-made" and benefit from a significant competitive advantage in public procurement. The new rules will impact a wide range of sectors, including healthcare, pharmaceuticals, research, environmental technologies, infrastructure, and industrial equipment.
This event will explore the practical implications for foreign companies operating in China, the role of localization and value-added manufacturing, and how businesses can prepare for the gradual introduction of product-specific standards over the coming years. Experts will discuss market access strategies, investment considerations, and the opportunities and challenges arising from China's evolving procurement landscape.
***
ไธญๅฝๆฐ็ๆฟๅบ้่ดญๆกๆถๅฐไบ2026ๅนด1ๆ่ตท็ๆ๏ผ่ฏฅๆกๆถๆ็กฎไบๅคๅฎไบงๅไฝๆถๅฏ่ขซ่งไธบ"ๅฝไบง"ๅนถๅ ๆญคๅจๆฟๅบ้่ดญไธญไบซๆๆพ่็ซไบไผๅฟ็ๆ ๅใๆฐ่งๅฐๅฝฑๅๅป็ไฟๅฅใๅถ่ฏใ็ง็ ใ็ฏไฟๆๆฏใๅบ็ก่ฎพๆฝๅๅทฅไธ่ฎพๅค็ญไผๅค้ขๅใ
ๆฌๆฌกๆดปๅจๅฐๆข่ฎจๅจๅ็ป่ฅ็ๅคๅฝไผไธ้ขไธด็ๅฎ้ ๅฝฑๅ๏ผๆฌๅฐๅๅๅขๅผๅถ้ ็ไฝ็จ๏ผไปฅๅไผไธๅฆไฝไธบๆชๆฅๅ ๅนด้ๆญฅๅฎๆฝ็ไบงๅไธ้กนๆ ๅๅๅฅฝๅๅคใไธๅฎถไปฌๅฐๅฐฑๅธๅบๅๅ ฅ็ญ็ฅใๆ่ต่้๏ผไปฅๅไธญๅฝไธๆญๅๅ็้่ดญๆ ผๅฑๆๅธฆๆฅ็ๆบ้ไธๆๆๅฑๅผ่ฎจ่ฎบใ
